Jilin Province Tuohua Biotechnology

Jilin Province Tuohua Biotechnology is a Chinese biotechnology company specializing in regenerative medicine and cell-based therapies. Based in Changchun, the company focuses on the research, development, and clinical application of mesenchymal stem cells (MSCs) and immune cells, such as Natural Killer (NK) cells. Tuohua operates a comprehensive platform that includes cell storage, preparation, and therapeutic development for various conditions, including liver diseases, orthopedic disorders, and oncology. The company's lead programs involve umbilical cord-derived MSCs for the treatment of liver cirrhosis and knee osteoarthritis. Tuohua aims to advance the field of precision medicine through its integrated cell technology infrastructure and collaborations with major clinical institutions in China. The company maintains high-standard GMP manufacturing facilities to support its clinical pipeline and commercial cell banking services.